This inventor holds 3 USPTO granted patents. Top assignees: Union Chimique Continentale-u.c.c, Laboratoires Hoechst S/a. Active years: 1978-1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978-1981
Title: Pierre Simon: Innovator in Psychostimulant Compounds
Introduction
Pierre Simon is a notable inventor based in Sèvres, France. He has made significant contributions to the field of chemistry, particularly in the development of psychostimulant compounds. With a total of 3 patents to his name, Simon's work has implications for pharmaceutical applications.
Latest Patents
Among his latest patents, Simon has focused on halogen derivatives of 8-hydroxycarboxylic acids. These compounds are designed to act as antidepressants with psychostimulant properties. His innovative processes involve creating halogen derivatives in both open and cyclized forms, which are suitable for pharmaceutical use. Additionally, he has developed tetrahydro-α-pyrones and their intermediate salts, which also exhibit psychostimulant activity. The preparation of these compounds involves a multi-step process, starting from the alkyl ester of a 5-oxo alkanoic acid and culminating in the formation of the desired psychostimulant compounds.
Career Highlights
Throughout his career, Pierre Simon has worked with prominent companies in the chemical industry. Notably, he has been associated with Union Chimique Continentale and Laboratoires Hoechst S.A. His experience in these organizations has contributed to his expertise in the field of chemical innovations.
Collaborations
Simon has collaborated with various professionals in his field, including Jacques Dreux. These partnerships have likely enhanced his research and development efforts, leading to his successful patent applications.
Conclusion
Pierre Simon's contributions to the field of psychostimulant compounds highlight his innovative spirit and dedication to advancing pharmaceutical chemistry. His patents reflect a commitment to developing effective antidepressants, showcasing the importance of his work in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile